本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kiniksa Pharmaceuticals Ltd.

80.20
+0.82001.03%
成交量:40.21萬
成交額:3,214.76萬
市值:62.58億
市盈率:81.01
高:80.86
開:79.36
低:79.13
收:79.38
52周最高:82.94
52周最低:32.89
股本:7,802.40萬
流通股本:3,927.92萬
量比:0.81
換手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):0.9900
每股收益(LYR):0.7500
淨資產收益率:14.04%
總資產收益率:8.05%
市淨率:9.57
市盈率(LYR):106.93

資料載入中...

2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/06/25

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/05

重要事件披露

Form 8-K - Current report
2024/04/25

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/23

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]